Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ZNTL | Zentalis Pharmaceuticals, Inc. | Chief Executive Officer, Director | $5.66M | Feb 1, 2024 | ||
IPSC | Century Therapeutics, Inc. | Director | Jun 20, 2024 | |||
GLUE | Monte Rosa Therapeutics, Inc. | Director | Jun 12, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|